(Q28212339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Arterial thrombosis in four patients treated with thalidomide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

0 references

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Sarah L Scarpace

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Theresa Hahn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Hilary Roy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Karen Brown

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Pamela Paplham

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Asher Chanan-Khan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Philip L McCarthy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

239-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Thromboembolism in patients on thalidomide for myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Thalidomide-associated deep vein thrombosis and pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Advances in biology of multiple myeloma: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

Thalidomide in the management of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015675

10.1080/10428190400015675

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621807%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference